Crossmark

Evaluation of multidisciplinary care pathways on kidney function in patients with advanced chronic kidney disease: multicenter study

Crossref DOI link: https://doi.org/10.1007/s40620-025-02365-8

Published Online: 2025-10-27

Published Print: 2025-12-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pagès, Hélène

Kosmadakis, Georges https://orcid.org/0000-0001-7973-6915
Kanouni, Fatima El

Nécoara, Aura

Baudenon, Julien

Deville, Clémence

Enache, Ioana

Murat-Ringot, Audrey

Verot, Elise
License Information

Version of Record valid from 2025-10-27

Text and Data Mining valid from 2025-10-27

Version of Record valid from 2025-10-27
More Information

Article History

Received: 14 January 2025

Accepted: 12 July 2025

First Online: 27 October 2025

Declarations

:

: All the authors declare no competing interests in regard to the present study.

: The study was approved by the ethics committee of Saint-Etienne on December 8, 2023, under the reference IRBN1502023/CHUSTE, and complied with CNIL's MR004 methodology, registered under no. 2231741v0. Use of the EQ-5D-5L required prior authorization from Euroquol, with registration number 59836 obtained for non-commercial use. The study was registered on ClinicalTrials.gov under the number NCT06219798, ensuring transparency and adherence to international standards.

: The present study complies with the guidelines for human studies.

: Informed consent was obtained from all individual participants included in the study.